Back

Association of growth differential factor-15, hs-cardiac troponin T and N-terminal pro-brain natriuretic peptide with coronary artery disease in patients undergoing elective coronary angiography

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Rabih Azar

St. Joseph University of Beyrouth, Beirut (Lebanon)

178 More presentations in this session

Presentation thumbnail
The quest for GRACE 3.0: improving our beloved risk score with machine learning
Doctor J. Sousa (Porto, PT)
Abstract Slides
Presentation thumbnail
Percutaneous coronary interventions in patients with left main coronary artery pseudobifurcation lesions: 5-years follow-up
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Use of intima media thickness in the assessment of the development of preclinical atherosclerosis
Associate Professor R. Najafov (Baku, AZ)
Abstract Slides
Presentation thumbnail
Long term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention
Doctor O. Kobo (Hadera, IL)
Abstract Slides
Presentation thumbnail
Feasibility, safety and long term outcomes of complex left main bifurcation treatment using the nano inverted t stenting: a multicentre registry
Associate Professor G. Rigatelli (Rovigo, IT)
Abstract Slides

Access the full session

Session thumbnail
Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of GDF-15 in patients with suspected myocardial infarction
1 September 2025
thumbnail
Congress Presentation
1 September 2019
thumbnail
Congress Presentation
The correlation between inflammatory biomarker and ejection fraction, and their evolution under the treatment with nebivolol vs bisoprolol in patients undergoing coronary angioplasty
2 March 2019
thumbnail
Congress Presentation
Severe coronary artery disease in young patients with no identifiable cardiovascular risk factors
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources